STS(SH:603322) Zheng Quan Zhi Xing·2025-06-25 16:47Core Viewpoint - The company is seeking to extend the authorization for the board of directors and its authorized personnel to fully manage the issuance of shares to specific targets, with the new authorization period set to last until 12 months after the second extraordinary general meeting of shareholders in 2025 [1][5]. Group 1 - The company held meetings on June 26 and July 12, 2023, to discuss the issuance of shares to specific targets, with the initial authorization valid for 12 months from the date of approval at the first extraordinary general meeting of shareholders in 2023 [1]. - On June 24, 2024, the company’s board of directors approved a proposal to extend the authorization for the issuance of shares, which will now expire on July 11, 2025 [1][2]. - The board of directors is requesting the shareholders' meeting to authorize them to handle all matters related to the issuance, including but not limited to the timing, quantity, price, and use of raised funds [2][3]. Group 2 - The authorization allows for adjustments to the issuance plan based on changes in policies, feedback, or regulatory requirements, excluding matters that require a new vote from the shareholders' meeting [3][4]. - The company will manage all related documentation and agreements, including underwriting and service agreements, and will handle necessary approvals and registrations with relevant authorities [4]. - The board aims to ensure the smooth progression of the share issuance process, with the authorization period extended to 12 months following the second extraordinary general meeting of shareholders in 2025 [5].